<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 26 May 2026 16:09:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 21  Filed by: Blume-Jensen Peter</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+21++Filed+by%3A+Blume-Jensen+Peter/26550009.html</link>
   <description>si-local-file:///var/storage/secattach/20260526/26550009.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+21++Filed+by%3A+Blume-Jensen+Peter/26550009.html</guid>
   <pubDate>Tue, 26 May 2026 16:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 21  Filed by: Blume-Jensen Peter</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+21++Filed+by%3A+Blume-Jensen+Peter/26550009.html</link>
   <description>si-local-file:///var/storage/secattach/20260526/26550009.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+21++Filed+by%3A+Blume-Jensen+Peter/26550009.html</guid>
   <pubDate>Tue, 26 May 2026 16:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  DEFA14A    Acrivon Therapeutics,                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Acrivon+Therapeutics%2C++++++++++++++++/26541515.html</link>
   <description>si-local-file:///var/storage/secattach/20260522/26541515.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Acrivon+Therapeutics%2C++++++++++++++++/26541515.html</guid>
   <pubDate>Fri, 22 May 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  DEFA14A    Acrivon Therapeutics,                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Acrivon+Therapeutics%2C++++++++++++++++/26541515.html</link>
   <description>si-local-file:///var/storage/secattach/20260522/26541515.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Acrivon+Therapeutics%2C++++++++++++++++/26541515.html</guid>
   <pubDate>Fri, 22 May 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Acrivon Therapeutics to Present at TD Cowen’s 7th Annual Oncology Innovation Summit</title>
   <link>http://www.streetinsider.com/Press+Releases/Acrivon+Therapeutics+to+Present+at+TD+Cowen%E2%80%99s+7th+Annual+Oncology+Innovation+Summit/26531458.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;WATERTOWN, Mass., May  21, 2026  (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary Generative Phosphoproteomics AP3 (Acrivon Predictive Precision Proteomics) platform deployed for rational drug design and predictive clinical development, today announced the company’s president and chief executive officer, Peter Blume-Jensen, M.D., Ph.D., will participate in a virtual fireside chat on Tuesday, May 26, 2026, at 9:00 a.m. ET at TD Cowen’s 7&lt;sup&gt;th&lt;/sup&gt; Annual Oncology Innovation Summit.&lt;/p&gt;  &lt;p&gt;The live and archived webcast of this event can be accessed through</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Acrivon+Therapeutics+to+Present+at+TD+Cowen%E2%80%99s+7th+Annual+Oncology+Innovation+Summit/26531458.html</guid>
   <pubDate>Thu, 21 May 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	  </item>
  <item>
   <title>Acrivon Therapeutics to Present at TD Cowen’s 7th Annual Oncology Innovation Summit</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Acrivon+Therapeutics+to+Present+at+TD+Cowen%E2%80%99s+7th+Annual+Oncology+Innovation+Summit/26531458.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;WATERTOWN, Mass., May  21, 2026  (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary Generative Phosphoproteomics AP3 (Acrivon Predictive Precision Proteomics) platform deployed for rational drug design and predictive clinical development, today announced the company’s president and chief executive officer, Peter Blume-Jensen, M.D., Ph.D., will participate in a virtual fireside chat on Tuesday, May 26, 2026, at 9:00 a.m. ET at TD Cowen’s 7&lt;sup&gt;th&lt;/sup&gt; Annual Oncology Innovation Summit.&lt;/p&gt;  &lt;p&gt;The live and archived webcast of this event can be accessed through</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Acrivon+Therapeutics+to+Present+at+TD+Cowen%E2%80%99s+7th+Annual+Oncology+Innovation+Summit/26531458.html</guid>
   <pubDate>Thu, 21 May 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: Shah Rajeev M.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Shah+Rajeev+M./26529318.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26529318.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Shah+Rajeev+M./26529318.html</guid>
   <pubDate>Wed, 20 May 2026 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: Shah Rajeev M.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Shah+Rajeev+M./26529318.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26529318.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Shah+Rajeev+M./26529318.html</guid>
   <pubDate>Wed, 20 May 2026 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: TOMSICEK MICHAEL JOHN</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+TOMSICEK+MICHAEL+JOHN/26529011.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26529011.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+TOMSICEK+MICHAEL+JOHN/26529011.html</guid>
   <pubDate>Wed, 20 May 2026 16:37:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: TOMSICEK MICHAEL JOHN</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+TOMSICEK+MICHAEL+JOHN/26529011.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26529011.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+TOMSICEK+MICHAEL+JOHN/26529011.html</guid>
   <pubDate>Wed, 20 May 2026 16:37:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: Palani Santhosh</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Palani+Santhosh/26528997.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26528997.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Palani+Santhosh/26528997.html</guid>
   <pubDate>Wed, 20 May 2026 16:36:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: Palani Santhosh</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Palani+Santhosh/26528997.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26528997.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Palani+Santhosh/26528997.html</guid>
   <pubDate>Wed, 20 May 2026 16:36:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: Shacham Sharon</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Shacham+Sharon/26529005.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26529005.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Shacham+Sharon/26529005.html</guid>
   <pubDate>Wed, 20 May 2026 16:36:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: Shacham Sharon</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Shacham+Sharon/26529005.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26529005.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Shacham+Sharon/26529005.html</guid>
   <pubDate>Wed, 20 May 2026 16:36:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: Magovcevic-Liebisch Ivana</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Magovcevic-Liebisch+Ivana/26528993.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26528993.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Magovcevic-Liebisch+Ivana/26528993.html</guid>
   <pubDate>Wed, 20 May 2026 16:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: Magovcevic-Liebisch Ivana</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Magovcevic-Liebisch+Ivana/26528993.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26528993.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Magovcevic-Liebisch+Ivana/26528993.html</guid>
   <pubDate>Wed, 20 May 2026 16:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: DiRocco Derek</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+DiRocco+Derek/26528968.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26528968.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+DiRocco+Derek/26528968.html</guid>
   <pubDate>Wed, 20 May 2026 16:34:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: DiRocco Derek</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+DiRocco+Derek/26528968.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26528968.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+DiRocco+Derek/26528968.html</guid>
   <pubDate>Wed, 20 May 2026 16:34:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: BAUM CHARLES M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+BAUM+CHARLES+M/26528953.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26528953.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+BAUM+CHARLES+M/26528953.html</guid>
   <pubDate>Wed, 20 May 2026 16:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: BAUM CHARLES M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+BAUM+CHARLES+M/26528953.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26528953.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+BAUM+CHARLES+M/26528953.html</guid>
   <pubDate>Wed, 20 May 2026 16:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: Peterson Katharine</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Peterson+Katharine/26528929.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26528929.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Peterson+Katharine/26528929.html</guid>
   <pubDate>Wed, 20 May 2026 16:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: Peterson Katharine</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Peterson+Katharine/26528929.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26528929.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Peterson+Katharine/26528929.html</guid>
   <pubDate>Wed, 20 May 2026 16:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: Levy Adam D.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Levy+Adam+D./26528870.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26528870.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Levy+Adam+D./26528870.html</guid>
   <pubDate>Wed, 20 May 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: Levy Adam D.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Levy+Adam+D./26528870.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26528870.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Levy+Adam+D./26528870.html</guid>
   <pubDate>Wed, 20 May 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
  <item>
   <title>Form  4          Acrivon Therapeutics,     For: May 18  Filed by: Miller Mary</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Miller+Mary/26528897.html</link>
   <description>si-local-file:///var/storage/secattach/20260520/26528897.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Acrivon+Therapeutics%2C+++++For%3A+May+18++Filed+by%3A+Miller+Mary/26528897.html</guid>
   <pubDate>Wed, 20 May 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50727910</category>
   	  </item>
 </channel>
</rss>
